SAN DIEGO, Aug. 9, 2018 /PRNewswire/ -- Biocept, Inc.
(NASDAQ: BIOC), a molecular diagnostics company commercializing and
developing proprietary liquid biopsy tests that provide clinically
actionable information to physicians to improve cancer treatment,
announces that it will release financial results for the three and
six months ended June 30, 2018, after
the market closes on Tuesday, August 14,
2018. The Company will host a conference call for the
investment community to discuss the results and answer questions at
4:30 p.m. Eastern time (1:30 p.m. Pacific time).
Individuals interested in participating on the conference call
may do so by dialing (855) 656-0927 for domestic callers, (855)
669-9657 for Canadian callers, or (412) 902-4109 for other
international callers. Those interested in listening to a webcast
of the live conference call may do so by visiting
https://www.webcaster4.com/Webcast/Page/1271/26832.
A replay of the conference call will be available for 48 hours
following the conclusion of the call by dialing (877) 344-7529 for
domestic callers, (855) 669-9658 for Canadian callers, or (412)
317-0088 for other international callers, and entering the replay
access code 10122826. A webcast replay will be available for 90
days at http://ir.biocept.com/events.cfm.
About Biocept
Biocept, Inc. is a molecular
diagnostics company with commercialized assays for lung, breast,
gastric, colorectal and prostate cancers, and melanoma. The Company
leverages its proprietary liquid biopsy technology to provide
physicians with clinically actionable information for treating and
monitoring patients diagnosed with cancer. Biocept's patented
Target Selector™ liquid biopsy technology platform captures and
analyzes tumor-associated molecular markers in circulating tumor
DNA (ctDNA) and on circulating tumor cells (CTCs). With thousands
of tests performed, the platform has demonstrated the ability to
identify cancer mutations and alterations to inform physicians
about a patient's disease and therapeutic options. For additional
information, please visit www.biocept.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/biocept-to-release-second-quarter-2018-financial-results-and-host-investor-conference-call-on-august-14-2018-300694926.html
SOURCE Biocept, Inc.